Nuvation Bio Inc. Debt Securities, Available-for-sale, Realized Gain
Nuvation Bio Inc. (NUVB) reported Debt Securities, Available-for-sale, Realized Gain of $20.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleRealizedGain · last filed 2026-08-06
- Nuvation Bio Inc. debt securities, available-for-sale, realized gain for the quarter ending 2026-06-30 was $20.00K.
- Nuvation Bio Inc. debt securities, available-for-sale, realized gain for the quarter ending 2026-03-31 was $8.00K, a 166.67% increase year-over-year.
- Nuvation Bio Inc. debt securities, available-for-sale, realized gain for the quarter ending 2025-12-31 was $3.00K, a 90.00% decline year-over-year.
- Nuvation Bio Inc. debt securities, available-for-sale, realized gain for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Nuvation Bio Inc. debt securities, available-for-sale, realized gain for fiscal 2025 was $6.00K, a 85.37% decline from fiscal 2024.
- Nuvation Bio Inc. debt securities, available-for-sale, realized gain for fiscal 2024 was $41.00K, a 41.43% decline from fiscal 2023.
- Nuvation Bio Inc. debt securities, available-for-sale, realized gain for fiscal 2023 was $70.00K, a 677.78% increase from fiscal 2022.
- Nuvation Bio Inc. debt securities, available-for-sale, realized gain for fiscal 2022 was $9.00K, a 89.77% decline from fiscal 2021.
| Period end | Debt Securities, Available-for-sale, Realized Gain 3 month | Debt Securities, Available-for-sale, Realized Gain 3 month as first filed | Debt Securities, Available-for-sale, Realized Gain 6 month | Debt Securities, Available-for-sale, Realized Gain 9 month | Debt Securities, Available-for-sale, Realized Gain 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $20.00K 10-Q · filed 2026-08-06 | $28.00K 10-Q · filed 2026-08-06 | $31.00K derived: sum of 3 quarters · filed 2026-08-06 | $31.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $8.00K 10-Q · filed 2026-05-04 | $11.00K derived: sum of 2 quarters · filed 2026-05-04 | $11.00K derived: sum of 3 quarters · filed 2026-05-04 | $11.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $3.00K derived: sum of 2 quarters · filed 2026-03-02 | $3.00K derived: sum of 3 quarters · filed 2026-08-06 | $6.00K 10-K · filed 2026-03-02 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-03 | $0.00 derived: sum of 2 quarters · filed 2026-08-06 | $3.00K 10-Q · filed 2025-11-03 | $33.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-06 | $3.00K 10-Q · filed 2026-08-06 | $33.00K derived: sum of 3 quarters · filed 2026-08-06 | $43.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $3.00K 10-Q · filed 2026-05-04 | $33.00K derived: sum of 2 quarters · filed 2026-05-04 | $43.00K derived: sum of 3 quarters · filed 2026-05-04 | $44.00K derived: sum of 4 quarters · filed 2026-05-04 | |
| 2024-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $40.00K derived: sum of 2 quarters · filed 2026-03-02 | $41.00K derived: sum of 3 quarters · filed 2026-03-02 | $41.00K 10-K · filed 2026-03-02 | |
| 2024-09-30 | $10.00K 10-Q · filed 2025-11-03 | $11.00K derived: sum of 2 quarters · filed 2025-11-03 | $11.00K 10-Q · filed 2025-11-03 | $55.00K derived: sum of 4 quarters · filed 2025-11-03 | |
| 2024-06-30 | $1.00K 10-Q · filed 2025-08-07 | $1.00K 10-Q · filed 2025-08-07 | $45.00K derived: sum of 3 quarters · filed 2025-08-07 | $60.00K derived: sum of 4 quarters · filed 2025-08-07 | |
| 2024-03-31 | $1.00K 10-Q · filed 2025-05-07 | $44.00K derived: sum of 2 quarters · filed 2025-05-07 | $59.00K derived: sum of 3 quarters · filed 2025-05-07 | $71.00K derived: sum of 4 quarters · filed 2025-05-07 | |
| 2023-12-31 | $43.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $58.00K derived: sum of 2 quarters · filed 2025-03-06 | $70.00K derived: sum of 3 quarters · filed 2025-03-06 | $70.00K 10-K · filed 2025-03-06 | |
| 2023-09-30 | $15.00K 10-Q · filed 2024-11-06 | $27.00K derived: sum of 2 quarters · filed 2024-11-06 | $27.00K 10-Q · filed 2024-11-06 | $27.00K derived: sum of 4 quarters · filed 2024-11-06 | |
| 2023-06-30 | $12.00K 10-Q · filed 2024-08-05 | $0.00 10-Q · filed 2023-08-03 | $12.00K 10-Q · filed 2024-08-05 | $12.00K derived: sum of 3 quarters · filed 2024-08-05 | $12.00K derived: sum of 4 quarters · filed 2024-08-05 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-14 | $0.00 derived: sum of 2 quarters · filed 2024-05-14 | $0.00 derived: sum of 3 quarters · filed 2024-05-14 | $2.00K derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $0.00 derived: sum of 2 quarters · filed 2024-02-29 | $2.00K derived: sum of 3 quarters · filed 2024-02-29 | $9.00K 10-K · filed 2024-02-29 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-03 | $2.00K derived: sum of 2 quarters · filed 2023-08-03 | $9.00K 10-Q · filed 2023-11-02 | $41.00K derived: sum of 4 quarters · filed 2023-08-03 | |
| 2022-06-30 | $2.00K 10-Q · filed 2023-08-03 | $9.00K 10-Q · filed 2023-08-03 | $41.00K derived: sum of 3 quarters · filed 2023-08-03 | $51.00K derived: sum of 4 quarters · filed 2023-08-03 | |
| 2022-03-31 | $7.00K 10-Q · filed 2023-05-04 | $39.00K derived: sum of 2 quarters · filed 2023-05-04 | $49.00K derived: sum of 3 quarters · filed 2023-05-04 | $50.00K derived: sum of 4 quarters · filed 2023-05-04 | |
| 2021-12-31 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $42.00K derived: sum of 2 quarters · filed 2023-03-15 | $43.00K derived: sum of 3 quarters · filed 2023-03-15 | $88.00K 10-K · filed 2023-03-15 | |
| 2021-09-30 | $10.00K 10-Q · filed 2022-11-03 | $11.00K derived: sum of 2 quarters · filed 2022-11-03 | $56.00K 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | $1.00K 10-Q · filed 2022-08-04 | $46.00K 10-Q · filed 2022-08-04 | |||
| 2021-03-31 | $45.00K 10-Q · filed 2022-05-09 | ||||
| 2020-12-31 | $313.00K 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B |